Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC

<iframe
  src="https://statesidedaily.com/embed/cluster/353e153dd59407d3896d1a9ca72d0447ffa95b95"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC"></iframe>